Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LIVSON VITA is an oral nutraceutical supplement developed and marketed by Shayana Farm, a pharmaceutical company based in Uzbekistan. Formulated as capsules, it is positioned as a hepatoprotective agent within the company's commercial product portfolio. The supplement typically contains a combination of silymarin (a flavonolignan complex derived from milk thistle) and essential B-complex vitamins, including thiamine, riboflavin, pyridoxine, cyanocobalamin, nicotinamide, and calcium pantothenate. Silymarin provides hepatoprotection by stabilizing hepatocyte membranes, inhibiting lipid peroxidation, and stimulating RNA polymerase I to promote ribosomal protein synthesis and liver regeneration. The B-vitamins act as vital cofactors in hepatic metabolic pathways, supporting detoxification and energy production. LIVSON VITA is used as a dietary supplement to support liver function in individuals with chronic liver diseases, toxic liver damage, or as a general health tonic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LIVSON VITA.